MHRA: Navigating The Authorised Human Medicines Brokers Register

• The MHRA maintains a public register of UK brokers authorized to deal in human medicines, detailing company names, registration numbers, and addresses.
• This register serves as a critical resource for national health regulators in other EEA member states to verify the legitimacy of UK brokers.
• Information on how to register as a broker is available, and inquiries regarding various pharmaceutical authorisations can be made via pcl@mhra.gov.uk.
• The UK medicine broker list MHRA is frequently updated, with new versions published regularly, sometimes multiple times within a month or year.
• Legal and compliance professionals can utilize this dynamic register for due diligence, ensuring adherence to MHRA regulatory requirements for pharmaceutical transactions.

Legal professionals and compliance officers can leverage this regularly updated register to conduct thorough due diligence on potential partners, verify the legitimacy and authorization status of human medicine brokers in the UK, and ensure their clients adhere to MHRA regulatory requirements for pharmaceutical transactions.

The Medicines and Healthcare products Regulatory Agency (MHRA) maintains a crucial public resource: the MHRA authorised human medicines brokers register. This comprehensive listing serves as an official record of UK-based entities permitted to broker human medicines, providing essential transparency within the pharmaceutical supply chain. Each entry on this register details the company name, its specific registration number, and its operational address, offering a clear snapshot of authorised operators.

This publicly accessible register is not only vital for domestic oversight but also plays a significant role in international regulatory cooperation. It enables national health regulators in other European Economic Area (EEA) member states to efficiently verify the legitimacy and authorisation status of UK brokers. The information is provided in a CSV format, with the current file size noted as 2.68 KB, though it comes with a disclaimer that it may not be suitable for users relying on assistive technology.

For entities involved in the pharmaceutical sector, understanding the requirements for human medicines broker registration is paramount. The MHRA provides guidance on how to register as a broker, ensuring that all operators meet the necessary standards for pharmaceutical broker compliance UK. The agency facilitates inquiries related to various authorisations, including broker registrations, through a dedicated email address, pcl@mhra.gov.uk. While broker registration applications are submitted via MHRA Submissions, and the PCL portal is used for other licence types such as wholesale distribution authorisations, active pharmaceutical ingredient registrations, and distance selling logo applications, this email address serves as a contact point for a broad spectrum of stakeholders, including holders of manufacturing and wholesale distribution authorisations, those with broker registrations, and active pharmaceutical ingredient (API) registration holders.

The integrity and reliability of the UK medicine broker list MHRA are underpinned by its consistent and frequent updates. This dynamic resource is regularly revised to reflect the most current information, with numerous updates documented across various months and years. For instance, the register has seen updates and publications for September 2026, August 2026, July 2026, and June 2026, demonstrating forward-looking maintenance. Past revisions include March 2026, February 2026, January 2026, and December 2025, alongside earlier entries for November 2025, September 2025, August 2025, and June 2025.

Further historical data shows updates for May 2025, December 2024, November 2024, October 2024, August 2024, May 2025, April 2025, February 2024, December 2023, November 2023, August 2023, March 2023, January 2023, September 2022, August 2022, July 2022, June 2022, May 2022, and April 2022. This continuous revision makes the MHRA authorised human medicines brokers register an indispensable tool for legal professionals and compliance officers. They can leverage this regularly updated register to conduct thorough due diligence on potential partners, verify the legitimacy and authorization status of human medicine brokers in the UK, and ensure their clients adhere to MHRA regulatory requirements for pharmaceutical transactions, thereby mitigating risks and fostering compliant operations.

Lawyers and compliance officers can use this regularly updated register to conduct due diligence on potential partners, verify the legitimacy and authorization status of human medicine brokers in the UK, and ensure their clients comply with MHRA regulatory requirements for pharmaceutical transactions.

Source: Original reporting via GOV.UK notice